|
|
|
|
LEADER |
01745nam a2200325 u 4500 |
001 |
EB001853657 |
003 |
EBX01000000000000001017960 |
005 |
00000000000000.0 |
007 |
tu||||||||||||||||||||| |
008 |
181108 r ||| eng |
100 |
1 |
|
|a Banerjee, Srabani
|
245 |
0 |
0 |
|a Eye movement desensitization and reprocessing for depression, anxiety, and post-traumatic stress disorder: a review of clinical effectiveness
|h Elektronische Ressource
|c Srabani Banerjee, Charlene Argaez
|
246 |
3 |
1 |
|a EMDR for Depression, Anxiety, and PTSD
|
250 |
|
|
|a Version: 1.0
|
260 |
|
|
|a Ottawa
|b Canadian Agency for Drugs and Technologies in Health
|c 2017, July 21, 2017
|
300 |
|
|
|a 1 PDF file (34 pages)
|b illustration
|
505 |
0 |
|
|a Includes bibliographical references
|
653 |
|
|
|a Comparative Effectiveness Research
|
653 |
|
|
|a Anxiety Disorders / therapy
|
653 |
|
|
|a Depressive Disorder / therapy
|
653 |
|
|
|a Eye Movement Desensitization Reprocessing
|
653 |
|
|
|a Stress Disorders, Post-Traumatic / therapy
|
700 |
1 |
|
|a Argáez, Charlene
|e [author]
|
710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|b Rapid Response Service
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
490 |
0 |
|
|a CADTH rapid response report: summary with critical appraisal
|
856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK519861
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
082 |
0 |
|
|a 610
|
520 |
|
|
|a The purpose of this report is to review the clinical effectiveness of eye-movement desensitization and reprocessing (EMDR) compared with other psychological treatments, treatment as usual, or no treatment for adult patients with depression, anxiety, or posttraumatic stress disorder (PTSD)
|